A study to assess the effects of efgartigimod on emasiprubart in healthy adult participants
This research is an early-stage study, sometimes called a Phase I trial. It's designed to understand how the body reacts to two new treatments, efgartigimod and emasiprubart, when given to healthy adult volunteers. The main goal is to see how these medicines are absorbed, distributed, broken down, and removed from the body. Researchers also want to check for any early signs of side effects. This type of study is really important because it helps scientists learn more about new medicines before they are tested in people who are unwell. It's a key first step in developing potential new treatments for various health conditions in the future.
At a glance
What is this study about?
This study is an early-stage research project, often called a 'Phase I' trial. The main purpose of this kind of study is to learn about how new medicines work in the body when given to healthy volunteers, rather than people with a specific illness. For this particular study, scientists are looking at two medicines called efgartigimod and emasiprubart. They want to understand how these medicines behave in the body, such as how long they stay there, how they are absorbed, and how they are eventually removed.
Learning about these things is a crucial first step in developing any new medicine. It helps researchers understand the right dose to use and if there are any early safety concerns. Even though these medicines aren't being used to treat a condition in this study, the information gathered is vital for future research that might explore their use for various health problems.
By taking part, healthy volunteers help scientists gather important information that could lead to new treatments down the line. It's a foundational study that paves the way for further research and development of these potential new medicines.
Key takeaways
- This is an early-stage study testing two new medicines in healthy adults.
- The main aim is to understand how these medicines work in the body.
- Participation involves health checks and taking the study medicine.
- Both men and women aged 18 and over can take part.
- Your health and safety would be closely monitored throughout the study.
- You can stop participating at any time if you change your mind.
Who may be eligible?
To join this study, you must be an adult, aged 18 years or older. There is no upper age limit mentioned, meaning older adults can also take part if they meet other criteria.
Both men and women are welcome to participate in this study. The research is open to all genders.
Since this is a study for healthy individuals, there will likely be other health checks and rules to make sure you are in good general health before you can join. These will ensure your safety during the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you generally in good health?
- Are you willing and able to attend study appointments?
- Do you understand what taking part in a research study involves?
- Are you available for the full duration of the study?
What does participation involve?
If you choose to take part in this study, you would be helping researchers learn more about how the new medicines, efgartigimod and emasiprubart, work in the body. You would likely need to attend several appointments at a research clinic. These visits would involve health checks, such as blood tests, urine tests, and possibly physical examinations to make sure you are healthy and to monitor how the medicines are affecting your body.
You would receive one or both of the study medicines, either efgartigimod or emasiprubart, as directed by the study doctors. The way the medicine is given (e.g., as an injection or by mouth) would be explained to you. After receiving the medicine, there would be follow-up appointments to continue monitoring your health and the levels of the medicine in your body. The total length of your involvement in the study, including all visits and follow-up, would be fully explained to you before you agree to take part.
Potential risks and benefits
Locations (1)
- —UnverifiedBelgium
Common questions
What kind of medicines are efgartigimod and emasiprubart?
These are new medicines being investigated by scientists. At this stage, the study is about understanding how they work in the body, not for treating a specific illness.
Why are only healthy adults taking part in this study?
This is an early-stage study, and it's important to first understand how a new medicine behaves in a healthy body before testing it in people who are unwell. This helps ensure safety.
Will I get paid to take part in this study?
Often, studies like this offer some payment for your time and to cover travel expenses. This will be fully explained to you by the research team.
What does 'Human Pharmacology (Phase I)' mean?
It means this is a very early stage of testing a new medicine in people. The main focus is on how the medicine affects the body and if it's safe at different doses.
What if I experience side effects during the study?
The research team will carefully monitor you for any side effects. If you experience anything unusual, you should report it immediately to them, and they will provide care and advice.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.